Activation of TRPV1 prevents OxLDL-induced lipid accumulation and TNF- α -Induced inflammation in macrophages: Role of liver X receptor α

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Zhao, Jin Feng ^a   Ching, Li Chieh ^a   Kou, Yu Ru ^a   Lin, Shing Jong ^b   Wei, Jeng ^c   Shyue, Song Kun ^d   Lee, Tzong Shyuan ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c CHENG HSIN GENERAL HOSPITAL   (Taiwan)

^d INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; CAPSAZEPINE; LIVER X RECEPTOR ALPHA; OXIDIZED LOW DENSITY LIPOPROTEIN; TUMOR NECROSIS FACTOR ALPHA; VANILLOID RECEPTOR 1; CALCIUM; CAPSAICIN; DRUG DERIVATIVE; LIVER X RECEPTOR; LOW DENSITY LIPOPROTEIN; ORPHAN NUCLEAR RECEPTOR; SMALL INTERFERING RNA; TRPV1 PROTEIN, MOUSE; VANILLOID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CALCIUM TRANSPORT; CONTROLLED STUDY; INFLAMMATION; LIPID STORAGE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; CELL CULTURE; CHEMICALLY INDUCED DISORDER; CHROMATIN IMMUNOPRECIPITATION; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; GENETICS; METABOLISM; WESTERN BLOTTING; AGONISTS; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; DRUG EFFECTS;

ANIMALS; ATHEROSCLEROSIS; BLOTTING, WESTERN; CALCIUM; CAPSAICIN; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; INFLAMMATION; LIPOPROTEINS, LDL; MACROPHAGES; MICE; ORPHAN NUCLEAR RECEPTORS; RNA, SMALL INTERFERING; TRPV CATION CHANNELS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84880148488     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/925171     Document Type: Article

References (60)

1. Glass C. K., Witztum J. L., Atherosclerosis: the road ahead. Cell 2001 104 4 503 516 2-s2.0-0035936802 10.1016/S0092-8674(01)00238-0 (Pubitemid 32201946)
2. Riccioni G., Zanasi A., Vitulano N., Mancini B., D'Orazio N., Leukotrienes in atherosclerosis: new target insights and future therapy perspectives. Mediators of Inflammation 2009 2009 6 2-s2.0-76749132769 10.1155/2009/737282 737282
3. Li A. C., Glass C. K., The macrophage foam cell as a target for therapeutic intervention. Nature Medicine 2002 8 11 1235 1242 2-s2.0-0036852744 10.1038/nm1102-1235 (Pubitemid 35373554)
4. Monaco C., Cole J. E., Georgiou E., The expression and functions of toll-like receptors in atherosclerosis. Mediators of Inflammation 2010 2010 18 2-s2.0-77955412192 10.1155/2010/393946 393946
5. Kunjathoor V. V., Febbraio M., Podrez E. A., Moore K. J., Andersson L., Koehn S., Rhee J. S., Silverstein R., Hoff H. F., Freeman M. W., Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. The Journal of Biological Chemistry 2002 277 51 49982 49988 2-s2.0-0346037268 10.1074/jbc.M209649200 (Pubitemid 36014449)
6. Rahaman S. O., Lennon D. J., Febbraio M., Podrez E. A., Hazen S. L., Silverstein R., A CD36-dependent signaling cascade is necessary for macrophage foam cell formation. Cell Metabolism 2006 4 3 211 221 2-s2.0-33747859314 10.1016/j.cmet.2006.06.007 (Pubitemid 44283954)
7. Van Eck M., Bos I. S. T., Hildebrand R. B., Van Rij B. T., Van Berkel T. J. C., Dual role for scavenger receptor class B, type I on bone marrow-derived cells in atherosclerotic lesion development. American Journal of Pathology 2004 165 3 785 794 2-s2.0-4344574038 (Pubitemid 39129286)
8. Joyce C. W., Amar M. J. A., Lambert G., Vaisman B. L., Paigen B., Najib-Fruchart J., Hoyt R. F. Jr., Neufeld E. D., Remaley A. T., Fredrickson D. S., Brewer H. B. Jr., Santarnarina-Fojo S., The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice. Proceedings of the National Academy of Sciences of the United States of America 2002 99 1 407 412 2-s2.0-0037039438 10.1073/pnas.012587699 (Pubitemid 34060374)
9. Lin C.-Y., Lee T.-S., Chen C.-C., Chang C.-A., Lin Y.-J., Hsu Y.-P., Ho L.-T., Endothelin-1 exacerbates lipid accumulation by increasing the protein degradation of the ATP-binding cassette transporter G1 in macrophages. Journal of Cellular Physiology 2011 226 8 2198 2205 2-s2.0-79955086901 10.1002/jcp.22556
10. Lee T.-S., Lin C.-Y., Tsai J.-Y., Wu Y.-L., Su K.-H., Lu K.-Y., Hsiao S.-H., Pan C.-C., Kou Y. R., Hsu Y.-P., Ho L.-T., Resistin increases lipid accumulation by affecting class A scavenger receptor, CD36 and ATP-binding cassette transporter-A1 in macrophages. Life Sciences 2009 84 3-4 97 104 2-s2.0-58049086150 10.1016/j.lfs.2008.11.004
11. Tsai J.-Y., Su K.-H., Shyue S.-K., Kou Y. R., Yu Y.-B., Hsiao S.-H., Chiang A.-N., Wu Y.-L., Ching L.-C., Lee T.-S., EGb761 ameliorates the formation of foam cells by regulating the expression of SR-A and ABCA1: role of haem oxygenase-1. Cardiovascular Research 2010 88 3 415 423 2-s2.0-78149337025 10.1093/cvr/cvq226
12. Lu K.-Y., Ching L.-C., Su K.-H., Yu Y.-B., Kou Y. R., Hsiao S.-H., Huang Y.-C., Chen C.-Y., Cheng L.-C., Pan C.-C., Lee T.-S., Erythropoietin suppresses the formation of macrophage foam cells: role of liver X receptor α Circulation 2010 121 16 1828 1837 2-s2.0-77951769190 10.1161/CIRCULATIONAHA.109. 876839
13. Sorrentino R., Morello S., Chen S., Bonavita E., Pinto A., The activation of liver X receptors inhibits toll-like receptor-9-induced foam cell formation. Journal of Cellular Physiology 2010 223 1 158 167 2-s2.0-75749131609 10.1002/jcp.22022
14. Venkatachalam K., Montell C., TRP channels. Annual Review of Biochemistry 2007 76 387 417 2-s2.0-34548632601 10.1146/annurev.biochem.75.103004.142819
15. Caterina M. J., Schumacher M. A., Tominaga M., Rosen T. A., Levine J. D., Julius D., The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997 389 6653 816 824 2-s2.0-0030777012 10.1038/39807 (Pubitemid 27462969)
16. Holzer P., Acid sensing by visceral afferent neurones. Acta Physiologica 2011 201 1 63 75 2-s2.0-78650047802 10.1111/j.1748-1716.2010.02143.x
17. Van Der Stelt M., Di Marzo V., Endovanilloids: putative endogenous ligands of transient receptor potential vanilloid 1 channels. European Journal of Biochemistry 2004 271 10 1827 1834 2-s2.0-2442636258 10.1111/j.1432-1033. 2004.04081.x (Pubitemid 38657337)
18. Lee L.-Y., Gu Q., Role of TRPV1 in inflammation-induced airway hypersensitivity. Current Opinion in Pharmacology 2009 9 3 243 249 2-s2.0-65749107679 10.1016/j.coph.2009.02.002
19. de Petrocellis L., Orlando P., Moriello A. S., Aviello G., Stott C., Izzo A. A., di Marzo V., Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation. Acta Physiologica 2012 204 2 255 266 2-s2.0-84855345743 10.1111/j.1748-1716.2011. 02338.x
20. Pearce L. V., Petukhov P. A., Szabo T., Kedei N., Bizik F., Kozikowski A. P., Blumberg P. M., Evodiamine functions as an agonist for the vanilloid receptor TRPV1. Organic & Biomolecular Chemistry 2004 2 16 2281 2286 2-s2.0-4644282932 10.1039/b404506h
21. Thomas K. C., Ethirajan M., Shahrokh K., Sun H., Lee J., Cheatham T. E. III, Yost G. S., Reilly C. A., Structure-activity relationship of capsaicin analogs and transient receptor potential vanilloid 1-mediated human lung epithelial cell toxicity. Journal of Pharmacology and Experimental Therapeutics 2011 337 2 400 410 2-s2.0-79955036984 10.1124/jpet.110.178491
22. Golech S. A., McCarron R. M., Chen Y., Bembry J., Lenz F., Mechoulam R., Shohami E., Spatz M., Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors. Molecular Brain Research 2004 132 1 87 92 2-s2.0-8844260491 10.1016/j.molbrainres.2004.08.025 (Pubitemid 39531355)
23. Yao X., Garland C. J., Recent developments in vascular endothelial cell transient receptor potential channels. Circulation Research 2005 97 9 853 863 2-s2.0-27644570051 10.1161/01.RES.0000187473.85419.3e (Pubitemid 41552670)
24. Baylie R. L., Brayden J. E., TRPV channels and vascular function. Acta Physiologica 2011 203 1 99 116 2-s2.0-80051658054 10.1111/j.1748-1716.2010. 02217.x
25. Yang D., Luo Z., Ma S., Wong W. T., Ma L., Zhong J., He H., Zhao Z., Cao T., Yan Z., Liu D., Arendshorst W. J., Huang Y., Tepel M., Zhu Z., Activation of TRPV1 by dietary capsaicin improves endothelium-dependent vasorelaxation and prevents hypertension. Cell Metabolism 2010 12 2 130 141 2-s2.0-78049443064 10.1016/j.cmet.2010.05.015
26. Wang L., Wang D. H., TRPV1 gene knockout impairs postischemic recovery in isolated perfused heart in mice. Circulation 2005 112 23 3617 3623 2-s2.0-33644875613 10.1161/CIRCULATIONAHA.105.556274 (Pubitemid 43739540)
27. Ching L.-C., Kou Y. R., Shyue S.-K., Su K.-H., Wei J., Cheng L.-C., Yu Y.-B., Pan C.-C., Lee T.-S., Molecular mechanisms of activation of endothelial nitric oxide synthase mediated by transient receptor potential vanilloid type 1. Cardiovascular Research 2011 91 3 492 501 2-s2.0-79960777946 10.1093/cvr/cvr104
28. Mbalaviele G., Abu-Amer Y., Meng A., Jaiswal R., Beck S., Pittenger M. F., Mark T., Marshak D. R., Activation of peroxisome proliferator-activated receptor- γ pathway inhibits osteoclast differentiation. The Journal of Biological Chemistry 2000 275 19 14388 14393 2-s2.0-0034640397 10.1074/jbc.275.19.14388 (Pubitemid 30339723)
29. Asztalos B. F., de la Llera-Moya M., Dallal G. E., Horvath K. V., Schaefer E. J., Rothblat G. H., Differential effects of HDL subpopulations on cellular ABCA1- and SR-BI-mediated cholesterol efflux. Journal of Lipid Research 2005 46 10 2246 2253 2-s2.0-25444442925 10.1194/jlr.M500187-JLR200 (Pubitemid 41377476)
30. Cheng L.-C., Su K.-H., Kou Y. R., Shyue S.-K., Ching L.-C., Yu Y.-B., Wu Y.-L., Pan C.-C., Lee T.-S., α -Lipoic acid ameliorates foam cell formation via liver X receptor α -dependent upregulation of ATP-binding cassette transporters A1 and G1. Free Radical Biology and Medicine 2011 50 1 47 54 2-s2.0-78650690453 10.1016/j.freeradbiomed.2010.10.706
31. Hansson G. K., Hermansson A., The immune system in atherosclerosis. Nature Immunology 2011 12 3 204 212 2-s2.0-79951669207 10.1038/ni.2001
32. Deng T., Zhang L., Ge Y., Lu M., Zheng X., Redistribution of intracellular calcium and its effect on apoptosis in macrophages: induction by oxidized LDL. Biomedicine and Pharmacotherapy 2009 63 4 267 274 2-s2.0-64749101184 10.1016/j.biopha.2008.04.008
33. Febbraio M., Podrez E. A., Smith J. D., Hajjar D. P., Hazen S. L., Hoff H. F., Sharma K., Silverstein R. L., Targeted disruption of the class B, scavenger receptor CD36 protects against atherosclerotic lesion development in mice. The Journal of Clinical Investigation 2000 105 8 1049 1056 2-s2.0-0034101821 (Pubitemid 30217689)
34. Cavelier C., Lorenzi I., Rohrer L., von Eckardstein A., Lipid efflux by the ATP-binding cassette transporters ABCA1 and ABCG1. Biochimica et Biophysica Acta 2006 1761 7 655 666 2-s2.0-33746287715 10.1016/j.bbalip.2006.04.012 (Pubitemid 44108746)
35. Silver D. L., Jiang X.-C., Arai T., Bruce C., Tall A. R., Receptors and lipid transfer proteins in HDL metabolism. Annals of the New York Academy of Sciences 2000 902 103 112 2-s2.0-0034043085 (Pubitemid 30389115)
36. Yvan-Charvet L., Ranalletta M., Wang N., Han S., Terasaka N., Li R., Welch C., Tall A. R., Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice. The Journal of Clinical Investigation 2007 117 12 3900 3908 2-s2.0-36849011221 10.1172/JCI33372 (Pubitemid 350224099)
37. Hasegawa K., Wakino S., Kanda T., Yoshioka K., Tatematsu S., Homma K., Takamatsu I., Sugano N., Hayashi K., Divergent action of calcium channel blockers on ATP-binding cassette protein expression. Journal of Cardiovascular Pharmacology 2005 46 6 787 793 2-s2.0-33644687864 10.1097/01.fjc.0000187976. 60262.bf (Pubitemid 44378251)
38. Iwamoto N., Lu R., Tanaka N., Abe-Dohmae S., Yokoyama S., Calmodulin interacts with ATP binding cassette transporter A1 to protect from calpain-mediated degradation and upregulates high-density lipoprotein generation. Arteriosclerosis, Thrombosis, and Vascular Biology 2010 30 7 1446 1452 2-s2.0-77953933427 10.1161/ATVBAHA.110.203927
39. Zhao J. F., Ching L. C., Huang Y. C., Molecular mechanism of curcumin on the suppression of cholesterol accumulation in macrophage foam cells and atherosclerosis. Molecular Nutrition & Food Research 2012 56 691 701
40. Soumian S., Albrecht C., Davies A. H., Gibbs R. G. J., ABCA1 and atherosclerosis. Vascular Medicine 2005 10 2 109 119 2-s2.0-21244503531 10.1191/1358863x05vm593ra (Pubitemid 40883248)
41. Brooks-Wilson A., Marcil M., Clee S. M., Zhang L.-H., Roomp K., Van Dam M., Yu L., Brewer C., Collins J. A., Molhuizen H. O. F., Loubser O., Ouelette B. F. F., Fichter K., Ashbourne-Excoffon K. J. D., Sensen C. W., Scherer S., Mott S., Denis M., Martindale D., Frohlich J., Morgan K., Koop B., Pimstone S., Kastelein J. J. P., Genest J. Jr., Hayden M. R., Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nature Genetics 1999 22 4 336 345 2-s2.0-0032813808 10.1038/11905 (Pubitemid 29369523)
42. Bodzioch M., Orsó E., Klucken J., The gene encoding ATP-binding cassette transporter I is mutated in Tangier disease. Nature Genetics 1999 22 4 347 351 2-s2.0-0032813809 10.1038/11914 (Pubitemid 29369524)
43. Zhu X., Lee J.-Y., Timmins J. M., Brown J. M., Boudyguina E., Mulya A., Gebre A. K., Willingham M. C., Hiltbold E. M., Mishra N., Maeda N., Parks J. S., Increased cellular free cholesterol in macrophage-specific Abca1 knock-out mice enhances pro-inflammatory response of macrophages. The Journal of Biological Chemistry 2008 283 34 22930 22941 2-s2.0-53149102864 10.1074/jbc.M801408200
44. Malik P., Berisha S. Z., Santore J., Agatisa-Boyle C., Brubaker G., Smith J. D., Zymosan-mediated inflammation impairs in vivo reverse cholesterol transport. Journal of Lipid Research 2011 52 5 951 957 2-s2.0-79955023084 10.1194/jlr.M011122
45. McGillicuddy F. C., de la Llera Moya M., Hinkle C. C., Inflammation impairs reverse cholesterol transport in vivo. Circulation 2009 119 8 1135 1145 2-s2.0-62649150750 10.1161/CIRCULATIONAHA.108.810721
46. Castrillo A., Joseph S. B., Vaidya S. A., Haberland M., Fogelman A. M., Cheng G., Tontonoz P., Crosstalk between LXR and Toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism. Molecular Cell 2003 12 4 805 816 2-s2.0-0242361567 10.1016/S1097-2765(03)00384-8 (Pubitemid 37352775)
47. Joseph S. B., Bradley M. N., Castrillo A., Bruhn K. W., Mak P. A., Pei L., Hogenesch J., O'Connell R. M., Cheng G., Saez E., Miller J. F., Tontonoz P., LXR-dependent gene expression is important for macrophage survival and the innate immune response. Cell 2004 119 2 299 309 2-s2.0-5444235922 10.1016/j.cell.2004.09.032 (Pubitemid 39360910)
48. Joseph S. B., Castrillo A., Laffitte B. A., Mangelsdorf D. J., Tontonoz P., Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nature Medicine 2003 9 2 213 219 2-s2.0-0037324340 10.1038/nm820 (Pubitemid 36227724)
49. Tsuji F., Murai M., Oki K., Seki I., Ueda K., Inoue H., Nagelkerken L., Sasano M., Aono H., Transient receptor potential vanilloid 1 agonists as candidates for anti-inflammatory and immunomodulatory agents. European Journal of Pharmacology 2010 627 1-3 332 339 2-s2.0-73449146940 10.1016/j.ejphar.2009. 10.044
50. Kang J.-H., Tsuyoshi G., Han I.-S., Kawada T., Kim Y. M., Yu R., Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet. Obesity 2010 18 4 780 787 2-s2.0-77950187437 10.1038/oby.2009.301
51. Alawi K., Keeble J., The paradoxical role of the transient receptor potential vanilloid 1 receptor in inflammation. Pharmacology & Therapeutics 2010 125 2 181 195 2-s2.0-77249125805 10.1016/j.pharmthera.2009.10.005
52. Chiou W.-F., Sung Y.-J., Liao J.-F., Shum A. Y.-C., Chen C.-F., Inhibitory effect of dehydroevodiamine and evodiamine on nitric oxide production in cultured murine macrophages. Journal of Natural Products 1997 60 7 708 711 2-s2.0-0030855524 10.1021/np960495z (Pubitemid 27318419)
53. Wang T., Wang Y., Yamashita H., Evodiamine inhibits adipogenesis via the EGFR-PKC α -ERK signaling pathway. FEBS Letters 2009 583 22 3655 3659 2-s2.0-71749101583 10.1016/j.febslet.2009.10.046
54. Hu Y., Fahmy H., Zjawiony J. K., Davies G. E., Inhibitory effect and transcriptional impact of berberine and evodiamine on human white preadipocyte differentiation. Fitoterapia 2010 81 4 259 268 2-s2.0-77950521443 10.1016/j.fitote.2009.09.012
55. Ma L., Zhong J., Zhao Z., Luo Z., Ma S., Sun J., He H., Zhu T., Liu D., Zhu Z., Tepel M., Activation of TRPV1 reduces vascular lipid accumulation and attenuates atherosclerosis. Cardiovascular Research 2011 92 3 504 513 2-s2.0-81055133078 10.1093/cvr/cvr245
56. Ching L. C., Chen C. Y., Su K. H., Implication of AMP-activated protein kinase in transient receptor potential vanilloid type 1-mediated activation of endothelial nitric oxide synthase. Molecular Medicine 2012 18 1 805 815
57. Wei J., Ching L. C., Zhao J. F., Essential role of transient receptor potential vanilloid type 1 in evodiamine-mediated protection against atherosclerosis. Acta Physiologica 2013 207 2 299 307
58. Li L., Chen J., Ni Y., TRPV1 activationn prevents nonalcoholic fatty liver through UCP2 upregulation in mice. Pflügers Archiv 2012 463 5 727 732
59. Zhang L. L., Liu D. Y., Ma L. Q., Luo Z. D., Cao T. B., Zhong J., Yan Z. C., Wang L. J., Zhao Z. G., Zhu S. J., Schrader M., Thilo F., Zhu Z. M., Tepel M., Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity. Circulation Research 2007 100 7 1063 1070 2-s2.0-34247168128 10.1161/01.RES.0000262653.84850.8b (Pubitemid 46598931)
60. Wittenburg H., Carey M. C., Biliary cholesterol secretion by the twinned sterol half-transporters ABCG5 and ABCG8. The Journal of Clinical Investigation 2002 110 5 605 609 2-s2.0-0036733732 10.1172/JCI200216548 (Pubitemid 34988782)